1,365 results on '"Ponzoni, M"'
Search Results
2. EAHP 2020 workshop proceedings, pediatric myeloid neoplasms
3. POS0371 ASSOCIATION OF IgG4-RELATED DISEASE WITH AN IMMUNOLOGIC RESPONSE TO CANCER
4. T.12.6: HHV8-NEGATIVE EFFUSION-BASED LARGE B-CELL LYMPHOMA (EB-LBCL): A RARE CAUSE OF DIARRHEA AND ASCITES
5. Bone marrow metastases: a systematic review of a neglected involvement in malignant melanoma
6. The WNT receptor ROR2 drives the interaction of multiple myeloma cells with the microenvironment through AKT activation
7. A practical algorithmic approach to mature aggressive B cell lymphoma diagnosis in the double/triple hit era: selecting cases, matching clinical benefit: A position paper from the Italian Group of Haematopathology (G.I.E.)
8. IMMUNOGLOBULIN CLASS DICTATES TRANSFORMATION TRAJECTORY AND BCR STATUS OF MYC/BCL2 DOUBLE‐HIT LYMPHOMA: BIOLOGY AND CLINICAL IMPLICATIONS
9. CONSOLIDATIVE HCT‐ASCT IS SUPERIOR TO NON‐MYELOABLATIVE CHEMO‐IMMUNOTHERAPY IN NEWLY‐DIAGNOSED PCNSL ‐ UPDATED RESULTS OF THE RANDOMIZED PHASE III MATRIX/IELSG43 TRIAL
10. THE IELSG39 TRIAL: EFFICACY OF FIRST‐LINE CHLAMYDIA PSITTACI ERADICATION WITH A SIX‐MONTH REGIMEN OF DOXYCYCLINE IN PATIENTS WITH STAGE‐I MALT LYMPHOMA OF THE OCULAR ADNEXAE
11. Corrigendum to “Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up”
12. Combination of the MEK inhibitor pimasertib with BTK or PI3K-delta inhibitors is active in preclinical models of aggressive lymphomas
13. A novel liposomal Clodronate depletes tumor-associated macrophages in primary and metastatic melanoma: Anti-angiogenic and anti-tumor effects
14. How to maximize the diagnostic rate of endoscopic biopsy during flexible ureteroscopy for upper tract urothelial carcinoma
15. Induction of iron excess restricts malignant plasma cells expansion and potentiates bortezomib effect in models of multiple myeloma
16. Loss of PRDM1/BLIMP-1 function contributes to poor prognosis of activated B-cell-like diffuse large B-cell lymphoma
17. sTRAIL coupled to liposomes improves its pharmacokinetic profile and overcomes neuroblastoma tumour resistance in combination with Bortezomib
18. COVID-19 in Heart Transplant Recipients: A Multicenter Analysis of the Northern Italian Outbreak
19. Correction to: A practical algorithmic approach to mature aggressive B cell lymphoma diagnosis in the double/triple hit era: selecting cases, matching clinical benefit
20. A Novel t(5;7)(q31;q21)/CDK6::IL3 in Immature T-cell Acute Lymphoblastic Leukemia With IL3 Expression and Eosinophilia
21. Beyond high-dose methotrexate and brain radiotherapy: novel targets and agents for primary CNS lymphoma
22. COVID-19 in Heart Transplant Recipients: A Multicenter Analysis of the Northern Italian Outbreak
23. The aetiology of B‐cell lymphoid malignancies with a focus on chronic inflammation and infections
24. Primary testicular diffuse large B-cell lymphoma displays distinct clinical and biological features for treatment failure in rituximab era: a report from the International PTL Consortium
25. EAHP 2020 workshop proceedings, pediatric myeloid neoplasms
26. P1397: CHRONICALLY REDUCED LEVELS OF THROMBOPOIETIN IMPAIR HEMATOPOIETIC STEM CELL FUNCTION AND MEGAKARYOCYTE BONE MARROW NICHE
27. Hematopoietic stem cell function in b-thalassemia is impaired and is rescued by targeting the bone marrow niche
28. A novel patient-derived tumorgraft model with TRAF1-ALK anaplastic large-cell lymphoma translocation
29. Minimal morphological criteria for defining bone marrow dysplasia: a basis for clinical implementation of WHO classification of myelodysplastic syndromes
30. Minimal morphological criteria for defining bone marrow dysplasia: a basis for clinical implementation of WHO classification of myelodysplastic syndromes
31. PROGNOSTIC FACTORS, MANAGEMENT AND OUTCOME OF AN INTERNATIONAL SERIES OF 41 PATIENTS WITH PRIMARY MEDIASTINAL LARGE B‐CELL LYMPHOMA (PMLBCL) AND CENTRAL NERVOUS SYSTEM (CNS) INVOLVEMENT
32. GENETIC AND PHENOTYPIC ATTRIBUTES OF SPLENIC MARGINAL ZONE LYMPHOMA
33. Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study
34. Over 30% of patients with splenic marginal zone lymphoma express the same immunoglobulin heavy variable gene: ontogenetic implications
35. Antigen receptor stereotypy across B-cell lymphoproliferations: the case of IGHV4-59/IGKV3-20 receptors with rheumatoid factor activity
36. Immunoglobulin gene repertoire in ocular adnexal lymphomas: hints on the nature of the antigenic stimulation
37. Ocular adnexal MALT lymphoma: an intriguing model for antigen-driven lymphomagenesis and microbial-targeted therapy
38. Role of 18FDG-PET/CT in detecting relapse during follow-up of patients with Hodgkin’s lymphoma
39. NY-ESO-1-SPECIFIC SINGLE EDITED T CELLS ENSURE TUMOR REJECTION WITHOUT INDUCING XENOGENEIC GVHD: PH-O096
40. OFF-TUMOR TARGET EXPRESSION LEVELS DO NOT PREDICT CAR-T CELL KILLING: A FOUNDATION FOR THE SAFETY OF CD44V6-TARGETED T CELLS: PH-O031
41. NON-LINEAR CLONAL EVOLUTION OF LEUKEMIA DRIVEN BY THE SELECTIVE IMMUNE PRESSURE OF ALLOGENEIC HSCT: PH-O014
42. Dual regulation of Myc by Abl
43. Addition of rituximab to chemotherapy overcomes the negative prognostic impact of cyclin E expression in diffuse large B-cell lymphoma
44. Prolonged survival in poor-risk diffuse large B-cell lymphoma following front-line treatment with rituximab-supplemented, early-intensified chemotherapy with multiple autologous hematopoietic stem cell support: a multicenter study by GITIL (Gruppo Italiano Terapie Innovative nei Linfomi)
45. Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients
46. Selection of antigen receptors in splenic marginal-zone lymphoma: further support from the analysis of the immunoglobulin light-chain gene repertoire
47. Autoantibodies against a 72-kDa ductal cell membrane glycoprotein in a patient affected by Sjögren's syndrome and gastric MALT lymphoma
48. Intravascular Lymphomatosis (IL) in a Child Mimicking a Posterior Fossa Tumor
49. Clinical implications of hepatitis C virus infection in MALT-type lymphoma of the ocular adnexa
50. Prevalence of chlamydial infection in a series of 108 primary cutaneous lymphomas
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.